Carter Bankshares, Inc. (CARE) Insider Trading

Last 12 months

Insiders bought $120k and sold $405k on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. PRESIDENT, CHIEF STRATEGY OFCR Bradford N. Langs sold $146k on May 12, 17% of their stake, outside a plan.

Net open-market

−$285k

1 buy · 7 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

1 / 4

executives and directors

Last open-market buy

May 2026

May 6, 2026

Get an email when CARE's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 11	Catharine L. Midkiff Director	SoldNo plan	1,000	$31.25	$31k	5.2%	Form 4
Sep 11	Catharine L. Midkiff Director	SoldNo plan	1,000	$31.25	$31k	5.2%	Form 4
Jul 30	Bradford N. Langs PRESIDENT, CHIEF STRATEGY OFCR	SoldNo plan	2,500	$34.54	$86k	7.0%	Form 4
Jul 30	Robert M. Bolton Director	SoldNo plan	1,500	$34.60	$52k	2.2%	Form 4
May 12	Bradford N. Langs PRESIDENT, CHIEF STRATEGY OFCR	SoldNo plan	5,500	$26.47	$146k	17%	Form 4
May 6	Elizabeth L. Walsh Director	Bought	4,575	$26.20	$120k	1.0%	Form 4
May 5	James W. Haskins Director	SoldNo plan	1,000	$26.04	$26k	1.5%	Form 4
Oct 30, 2025	Robert M. Bolton Director	SoldNo plan	1,901	$17.23	$33k	2.7%	Form 4
Sep 10, 2025	Matthew M. Speare SEVP, CHIEF OPERATING OFFICER	SoldNo plan	13,550	$19.83	$269k	38%	Form 4
Aug 26, 2025	Wendy S. Bell SENIOR EXECUTIVE VP, CFO	SoldNo plan	250	$19.54	$5k	0.7%	Form 4
Jul 30, 2025	Catharine L. Midkiff Director	SoldNo plan	2,000	$17.76	$36k	11%	Form 4
Jul 28, 2025	James W. Haskins Director	SoldNo plan	2,000	$17.84	$36k	3.0%	Form 4
Jun 12, 2025	Kevin S. Bloomfield Director	SoldNo plan	1,629	$16.81	$27k	9.0%	Form 4
Jun 11, 2025	Kevin S. Bloomfield Director	SoldNo plan	4,509	$16.71	$75k	20%	Form 4
Jun 11, 2025	Kevin S. Bloomfield Director	SoldNo plan	1,629	$16.81	$27k	9.0%	Form 4
Jun 10, 2025	Kevin S. Bloomfield Director	SoldNo plan	4,509	$16.71	$75k	20%	Form 4
Jun 9, 2025	Kevin S. Bloomfield Director	SoldNo plan	1,000	$16.52	$17k	4.2%	Form 4
Jun 6, 2025	Kevin S. Bloomfield Director	SoldNo plan	1,000	$16.52	$17k	4.2%	Form 4
Jun 5, 2025	Jane Ann Davis EVP, CHIEF ADMIN. OFFICER	SoldNo plan	2,500	$16.39	$41k	17%	Form 4
Jun 2, 2025	Catharine L. Midkiff Director	Bought	200	$16.47	$3k	1.0%	Form 4

Sep 11No plan
Catharine L. Midkiff
Director · sold 1,000 at $31.25
$31k
5.2% of stake
Sep 11No plan
Catharine L. Midkiff
Director · sold 1,000 at $31.25
$31k
5.2% of stake
Jul 30No plan
Bradford N. Langs
PRESIDENT, CHIEF STRATEGY OFCR · sold 2,500 at $34.54
$86k
7.0% of stake
Jul 30No plan
Robert M. Bolton
Director · sold 1,500 at $34.60
$52k
2.2% of stake
May 12No plan
Bradford N. Langs
PRESIDENT, CHIEF STRATEGY OFCR · sold 5,500 at $26.47
$146k
17% of stake
May 6
Elizabeth L. Walsh
Director · bought 4,575 at $26.20
$120k
1.0% of stake
May 5No plan
James W. Haskins
Director · sold 1,000 at $26.04
$26k
1.5% of stake
Oct 30, 2025No plan
Robert M. Bolton
Director · sold 1,901 at $17.23
$33k
2.7% of stake
Sep 10, 2025No plan
Matthew M. Speare
SEVP, CHIEF OPERATING OFFICER · sold 13,550 at $19.83
$269k
38% of stake
Aug 26, 2025No plan
Wendy S. Bell
SENIOR EXECUTIVE VP, CFO · sold 250 at $19.54
$5k
0.7% of stake
Jul 30, 2025No plan
Catharine L. Midkiff
Director · sold 2,000 at $17.76
$36k
11% of stake
Jul 28, 2025No plan
James W. Haskins
Director · sold 2,000 at $17.84
$36k
3.0% of stake
Jun 12, 2025No plan
Kevin S. Bloomfield
Director · sold 1,629 at $16.81
$27k
9.0% of stake
Jun 11, 2025No plan
Kevin S. Bloomfield
Director · sold 4,509 at $16.71
$75k
20% of stake
Jun 11, 2025No plan
Kevin S. Bloomfield
Director · sold 1,629 at $16.81
$27k
9.0% of stake
Jun 10, 2025No plan
Kevin S. Bloomfield
Director · sold 4,509 at $16.71
$75k
20% of stake
Jun 9, 2025No plan
Kevin S. Bloomfield
Director · sold 1,000 at $16.52
$17k
4.2% of stake
Jun 6, 2025No plan
Kevin S. Bloomfield
Director · sold 1,000 at $16.52
$17k
4.2% of stake
Jun 5, 2025No plan
Jane Ann Davis
EVP, CHIEF ADMIN. OFFICER · sold 2,500 at $16.39
$41k
17% of stake
Jun 2, 2025
Catharine L. Midkiff
Director · bought 200 at $16.47
$3k
1.0% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CARE, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: National Commercial Banks

DCBGDime Commercial Bancshares, Inc.

WAFDWaFd, Inc.

FUNCFirst United Corporation

SHBIShore Bancshares Inc.

ASRVAmeriServ Financial Inc.

NBHCNational Bank Holdings Corporation

NKSHNational Bankshares Inc.

CBKMConsumers Bancorp Inc.

Spot a number that looks wrong? Check it in CARE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CARE

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.